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Background: Sleep apnea is accompanied by some cardiovascular complications. It has even been hypothesized that sleep 
apnea, itself, can induce some of these complications. Given such controversies, we assessed the left ventricular mass index 
(LVMI) and systolic pulmonary artery pressure in patients with sleep apnea.
Methods: Through convenience sampling, 56 patients with the obstructive sleep apnea syndrome (OSAS) were included 
in the present descriptive cross-sectional study. Patients with any past history of hypertension and diabetes mellitus were 
excluded. The apnea severity was assessed via the polysomnography-derived apnea-hypopnea index (AHI). All the patients 
underwent transthoracic echocardiography. In this cross-sectional study - data regarding age, gender, smoking, systolic and 
diastolic blood pressures, polysomnographic parameters (AHI, severity of disease, mean heart rate, mean oxygen saturation 
[SaO2], lowest SaO2, and duration of SaO2 below 90% [d.SaO2 < 90%]), and  echocardiographic parameters (systolic 
pulmonary artery pressure and LVMI) were accumulated and processed.
Results: Fifty-two men and 14 women at a mean age of 49.29 ± 11.79 years participated in this study. Systolic and was 
significantly high in the severe group compared with the mild group (128.21 ± 9.73 mmHg vs. 119.23 ± 12.5 mmHg; p value 
= 0.007). The LVMI was increased parallel to an increase in the severity of the OSAS, but that increase was not statistically 
significant (p value = 0.161). The d.SaO2 < 90% was positively correlated with the LVMI, and this relationship remained true 
after adjustment for the body mass index (r = 0.27; p value = 0.042).
Conclusion: Severe OSAS was accompanied by a higher blood pressure. The LVMI did not differ significantly between the 
patients with the OSAS and those who did not suffer from other risk factors of cardiac diseases.
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Abstract
Introduction
sleep-disordered breathing includes the obstructive sleep 
apnea syndrome (OSAS) and the upper airway resistance 
syndrome. Epidemiological studies based on the general 
population or the community-based cohort between 30 and 
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60 years of age estimate that 2 to 5% of the population is 
affected by the OSAS.1 The OSAS is known as the upper 
respiratory tract occlusion leading to the complete or partial 
cessation of the air flow. Hypoxia and ventilatory efforts are 
the consequences of this condition, and transient arousal 
occurs to improve the air flow.  An obstructive apnea is the 
absence of the air flow accompanied by ventilatory efforts 
for at least 10 seconds. A hypopnea is considered clinically 
significant if it is associated with a central nervous system 
arousal or with an oxyhemoglobin desaturation event (a 
decrease in blood oxygen saturation [SaO2] by 3 to 4% or 
more).1 The apnea-hypopnea index (AHI) is the total number 
of apneas and hypopneas per hour of sleep. The AHI is a 
common and useful index for evaluating the severity of the 
OSAS. Patients are classified into three groups based on 
their AHI: mild (AHI, 5 to 15), moderate (AHI, 15 to 30), 
and severe (AHI ≥ 30).1 Several causes have been mentioned 
to explain how the cardiovascular complications are related 
to the OSAS- including increased sympathetic activity in 
response to hypoxia and hypercapnia, which itself causes 
vasoconstriction, acute tachycardia, acute blood pressure 
elevation, and decrease in cardiovascular variability.2, 3 The 
OSAS is prevalent in patients with cardiovascular disease. It 
has been estimated that 50% of patients with hypertension, 
33% with coronary artery disease, 50 to 60% with myocardial 
infarction, 30 to 40% with systolic heart failure, and 
50% with atrial fibrillation requiring cardioversion suffer 
from the OSAS.2 On the other hand, some cardiovascular 
complications are presumed to be the consequences of 
the OSAS. This relationship may be caused by the OSAS 
comorbidities such as obesity and metabolic dysregulations. 
However, according to observational studies, the OSAS - 
itself - may lead to or worsen cardiovascular complications.
Methods
Fifty-eight patients diagnosed with the OSAS via 
polysomnography were enrolled in this cross-sectional study, 
conducted from March 2011 to May 2013. Unfortunately, 
recruiting only a small population with sleep disorders 
having undergone polysomnography and accepted to 
undergo echocardiography was one of the major limitations 
to our study. The patients underwent polysomnography in 
Nour Sleep Disorders Clinic, followed by echocardiography 
in Rasoul-e-Akram Hospital, Tehran, Iran. The study was 
performed in accordance with the Declaration of Helsinki and 
subsequent revisions. Furthermore, the Ethics Committee of 
Iran University of Medical Sciences approved the protocol 
before the study was commenced. Two patients were 
excluded from the study because of the diagnosis of severe 
mitral stenosis and myopathy due to frequent premature 
ventricular contractions on echocardiography. Patients with 
hypertension, diabetes mellitus, chronic kidney disease, 
cardiomyopathy, and any past history of cardiopulmonary 
diseases as well as individuals with the AHI < 5 assumed 
as the normal population1 were excluded from the study. 
Transthoracic echocardiography was performed by a 
single fellow of echocardiography. The echocardiographer 
was blinded to the patients’ polysomnography report. A 
manual check list was devised for data collection. The data 
encompassed age, gender, smoking, systolic and diastolic 
blood pressures, polysomnographic parameters (the AHI, 
severity of disease, mean heart rate, mean SaO2, lowest SaO2, 
and duration of SaO2 (d.SaO2) < 90%, and echocardiographic 
parameters (systolic pulmonary artery pressure and left 
ventricular mass index [LVMI]). The (LVMI) was calculated 
according to the Devereux formula. The LVMI was calculated 
by the correction of the left ventricular mass (LVM) for the 
body surface area. The normal threshold for the LVMI was 
defined < 96 for women and < 116 for men.4 The patients 
were divided into three groups according to their AHI: mild 
(AHI, 5 to 15), moderate (AHI, 15 to 30), and severe (AHI 
≥ 30).  For the statistical analyses, the statistical software 
SPSS version 13 for Windows (SPSS Inc., Chicago, IL) was 
used. The quantitative variables were presented as means ± 
standard deviations for the normally distributed variables and 
as medians (interquartile ranges) for the variables without 
normal distribution. The categorical data were presented 
as numbers and percentages. The categorical data were 
compared using the chi-square test, whereas the quantitative 
ones were compared using the one-way analysis of variance 
and the Kruskal–Wallis test, as appropriate. Relationships 
were assessed using the Pearson correlation test, Spearman 
test, or Kendall test based on their distribution. All p values 
were two-tailed, and a p value < 0.05 was considered 
statistically significant.
Results
The 56 eligible patients recruited in this study were 
comprised of 42 (75%) men and 14 (25%) women. The mean 
age was 49.29±11.79 years old, and the mean body mass 
index (BMI) was 28.12 ± 3.59 kg/m2 (Table 1). Thirteen 
(23.2%) patients had mild OSAS with a mean AHI of 7.23 ± 
1.61 (Group I). Fifteen (26.8%) patients were in the moderate 
group (Group II) (AHI, 23.05 ± 3.97) and 28 (50%) were 
in the severe group (Group III) (AHI, 61.17 ± 24.07). The 
demographic data and echocardiographic parameters were 
compared between the groups. No significant differences 
were detectable between the groups concerning age (p value 
= 0.581), whereas systolic blood pressure was significantly 
high in the severe group compared with the mild group 
(128.21 ± 9.73 mmHg vs. 119.23 ± 12.5 mmHg; p value = 
0.007). Additionally, a lower diastolic blood pressure was 
demonstrated in the mild group than in both the moderate 
and severe groups (p value = 0.487) (Table 2). The BMI 
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differed significantly between Group I (26.63 ± 3.36 kg/m2) 
and Group III (29.25 ± 4.06 kg/m2), (p value = 0.022). A 
partial correlation was used with controlling for the body 
mass index (BMI). There were no significant differences 
between the groups regarding systolic pulmonary artery 
pressure (p value = 0.953). The LVMI was increased parallel 
to an increase in the OSAS severity, but that increase failed 
to constitute statistical significance (p value = 0.095) (Table 
2). Six patients were diagnosed with LV hypertrophy; 4 
(66.6%) of these patients were in Group III. Significant 
correlations were detected between the BMI and each of the 
hypoxic parameters - including the AHI, mean SaO2, lowest 
SaO2, and d.SaO2 < 90% (p value = 0.002, p value = 0.010, p 
value = 0.001, and p value < 0.001, respectively). Similarly, 
a significant positive correlation was detected between the 
BMI and systolic blood pressure (p value = 0.003). Although 
the initial analysis showed a negative correlation between 
systolic blood pressure and mean SaO2 (r = - 0.29; p value 
= 0.020), a negative correlation between systolic blood 
pressure and lowest SaO2 (r = - 0.27; p value = 0.041), and 
a positive correlation between systolic blood pressure and 
d.SaO2 < 90% (r = 0.34; p value = 0.009), these relationships 
were not confirmed after adjustment for the BMI. The LVMI 
was positively correlated with d.SaO2 < 90%, even after 
adjustment for the BMI (r = 0.27; p value = 0.042). There 
were no statistically significant correlations between the 
LVMI and the other hypoxemic parameters - including the 
AHI (r = 0.32), mean SaO2 (r = -0.24), and lowest SaO2 (r 
= -0.19).
Discussion
Fifty-six patients  with  the OSAS  participated  in 
our  cross-sectional  study  and  underwent  transthoracic 
echocardiography. The initial analysis showed correlations 
between systolic blood pressure and hypoxemic parameters, 
but these relationships were not confirmed after adjustment 
for the BMI in our study. A 4-year study on 709 subjects 
demonstrated that the OSAS was a risk factor for elevating 
blood pressure after adjustment for age, gender, neck 
circumference, and the BMI.5 Another 4-year study 
established a rise in blood pressure and its strong and 
independent relationship with the OSAS.6 Based on our data, 
the BMI differed significantly in between Group I (26.63 ± 
3.36 kg/m2) and Group III (29.25 ± 4.06 kg/m2), and there 
were significant correlations between the BMI and each of 
the hypoxemic parameters - including the AHI, mean SaO2, 
lowest SaO2, and d.SaO2 < 90%.
7 Our results also revealed no 
significant differences between the groups apropos pulmonary 
artery pressure. The LVMI was increased in tandem with a 
rise in the OSAS severity in our study; the increase, however, 
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Table 2. Comparison of the variables between the groups*
Mild Sleep Apnea Moderate Sleep Apnea Severe Sleep Apnea P value
Age (y) 74.31±10.78 47.93±13.8 50.93±11.25 0.581
BMI (kg/m2) 26.63±3.36 27.32±2.01 29.25±4.06 0.007
PAP (mm Hg) 29.62±3.20 29.33±3.71 29.29±3.25 0.953
SBP (mm Hg) 119.23±12.05 124.67±6.39 128.21±9.73 0.037
DBP (mm Hg) 70.00±9.12 76.67±7.23 75.36±6.07 0.487
LVMI 71.8 (63.35-86.25) 74.6 (63.84-86.02) 80.53 (71.46-105.23) 0.095
*Data are presented as mean±SD or median (interquartile ranges).
BMI, Body mass index; PAP, Pulmonary artery pressure; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; LVMI, Left ventricular mass 
index






AHI (per hour) 29.5 (16.78-61.90)
Mean SaO2 (%) 92.85 (91.08-93.95)
Lowest SaO2 (%) 79.50 (76.00-86.00)
d.SaO2 90% (min) 17.15 (2.00-60.20)
LVMI (g/m2) 77.41 (66.38-91.99)
*Data are presented as mean±SD or median (interquartile ranges).
BMI, Body mass index; PAP, Pulmonary artery pressure; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; AHI, Apnea-hypopnea index; SaO2, 
Saturation of oxygen; d.SaO2 < 90%, Duration of oxygen saturation below 90%; LVMI, Left ventricular mass index
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was not statistically significant. The LVMI was positively 
correlated with the d.SaO2 < 90%, even after adjustment for 
the BMI. This relationship was not true between the LVMI 
and the other hypoxemic parameters - including the AHI, 
mean SaO2, and lowest SaO2. In our study, 6 patients had 
LV hypertrophy; 4 (66.6%) of these patients were in the 
severe apnea group. It has been previously reported that the 
OSAS is an independent predictor for the occurrence of LV 
hypertrophy.8 Nonetheless, a study performed between 1990 
and 1998 on patients with the OSAS demonstrated that the 
LV hypertrophy in these patients was associated with higher 
age, obesity, and hypertension.9 Dursunoglu et al10 reported 
that the LVMI in patients with the AHI ≥ 15 was higher 
than that in individuals with the AHI < 15. Another study 
on 28 patients with the OSAS without any past history of 
cardiovascular diseases showed LV hypertrophy in 21%; 
nevertheless, the effect of age and the BMI were not taken 
into consideration in this study (Gorzewska  A, Drozdowski 
J, Jerzemowska  A, Cynowska B, Porzezinska  M, Kedziora 
K, Grzenkowicz MS, Slominski JM, Cardiovascular 
complications in obstructive sleep apnoea: Early signs of 
cardiovascular system dysfunction in obstructive sleep 
apnea (OSA) patients before clinical manifestation, Hall 
2009,15:3686). It has been believed that LV hypertrophy 
in patients with the OSAS was independent of the other 
risk factors and that there was a relationship between this 
complication and O2 desaturation (Angeles Fernandez Jorge 
M, Luis Delgado J, Ruiz, Gloria Sobrino T, Antonio Iglasias 
J, Cardiovascular complications in obstructive  sleep  apnoea: 
Left ventricular hypertrophy (LVH) and diastolic dysfunction 
(DD) in obstructive sleep apnea (SAHS) patients. Hall 2009, 
15:3698.). In another study on 50 patients with the OSAS, 
all the patients who were diagnosed with LV hypertrophy 
suffered from hypertension and the LVMI was strongly 
associated with the d.SaO2 < 90%.
11 According to another 
study, the relationship between the severity of the OSAS 
and LV thickness was weakened by an increase in age and 
smoking and was invigorated by hypertension.12
Conclusion
Severe OSAS is accompanied by a higher blood pressure. 
Whereas the LVMI did not differ significantly between the 
patients with the OSAS who were not heavy smokers and 
did not suffer from hypertension and/or diabetes mellitus, 
LV hypertrophy occurred more frequently in those with 
severe OSAS (66%) than in those who belonged to the mild 
and moderate groups. Finally, an increase in the LVMI was 
correlated with a rise in the d.SaO2 < 90%.
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